PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
25-Oct-2024 Success Stories: Graduates of Clinical Research Courses with 100% Placement Fusion Technology Solutions
23-Oct-2024 Ten businesses embark on Discovery Park’s ‘Discovery Spark’ programme Discovery Park
23-Oct-2024 New genetic screening programme should be extended to test for untreatable conditions, says leading biotech Innovate UK
23-Oct-2024 New genetic screening programme should be extended to test for untreatable conditions, says leading biotech SynaptixBio
23-Oct-2024 ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares ProQR Therapeutics
23-Oct-2024 ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement ProQR Therapeutics N.V.
23-Oct-2024 ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement ProQR Therapeutics
23-Oct-2024 4Tissue Raises €2M to Advance Groundbreaking Breast Tissue Replacement Technology 4Tissue
23-Oct-2024 Capital Markets Event 2024: Lundbeck to showcase progress on Focused Innovator Strategy driving sustainable long-term growth H. Lundbeck A/S
23-Oct-2024 DARZALEX® (daratumumab)-SC based quadruplet regimen approved by the European Commission for patients with newly diagnosed multiple myeloma who are transplant-eligible Janssen-Cilag International NV
23-Oct-2024 Senzime secures first European hospital order for its new next-generation TetraGraph system Senzime
23-Oct-2024 Biocartis announces six Idylla™ abstracts to be presented at AMP 2024 Annual Meeting Biocartis NV
23-Oct-2024 ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement ProQR Therapeutics
23-Oct-2024 LILLY RECEIVES MHRA MARKETING AUTHORISATION IN GREAT BRITAIN FOR DONANEMAB (KISUNLA ®▼) FOR THE TREATMENT OF MILD COGNITIVE IMPAIRMENT AND MILD DEMENTIA DUE TO ALZHEIMER’S DISEASE IN ADULT PATIENTS WHO ARE APOLIPOPROTEIN E ε4 HETEROZYGOTES OR NON-CARRIERS Eli Lilly and Company Limited
23-Oct-2024 OKYO Pharma Announces First Patient Dosed in the First Clinical Trial to Treat Neuropathic Corneal Pain OKYO Pharma Limited
23-Oct-2024 AMYRA Successfully Demonstrates a New Therapeutic Paradigm for Gluten-Related Disorders in a First-in-Human Study AMYRA Biotech
23-Oct-2024 Online vs. On-Campus Clinical Research Courses: Which is Right for You? Fusion Technology Solutions
22-Oct-2024 Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection Recursion
22-Oct-2024 Quell Therapeutics to Present Promising Data from Autologous and Allogenic CAR-Treg Programs at Upcoming International Congresses Quell Therapeutics
22-Oct-2024 Wobble Genomics Presents Novel Early Detection Technology Demonstrating Exceptional Accuracy in Early-Stage Breast Cancer Wobble Genomics